GlassScriptPhysician profile
Daniel Zhidi Liu
NPI 1104931286
$47,112.80
in general payments reported to CMS, 2019-2025
31 companies · $2,444 in 2025
The $2,444 reported for 2025 was more than what 86% of Plastic and Reconstructive Surgery providers received nationally (typical 2025 total: $445).
See the full distribution for Plastic and Reconstructive Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $24K · 2020: $121 · 2021: $11K · 2022: $2,555 · 2023: $3,939 · 2024: $3,611 · 2025: $2,444.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $4,450 · Consulting Fee: $2,558 · Food and Beverage: $1,786 · Honoraria: $1,200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $4,450.00 |
| Consulting Fee | $2,557.50 |
| Food and Beverage | $1,786.25 |
| Honoraria | $1,200.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Surgalign Spine Technologies, INC. | $22,909.14 | 2019 | |
| Rti Surgical, INC | $20,118.32 | 2021-2025 | |
| Becton, Dickinson and Company | $987.50 | 2024 | |
| W. L. Gore & Associates, INC. | $900.00 | 2025 | Product In Development |
| Novartis Pharmaceuticals Corporation | $364.64 | 2019-2024 | |
| Medtronic, INC. | $205.00 | 2022-2024 | Surgipro Ll, Ta, Nuvent |
| Merck Sharp & Dohme LLC | $202.73 | 2020-2024 | Keytruda, Lynparza, Welireg |
| Amgen INC. | $181.97 | 2019 | |
| Lilly USA, LLC | $147.65 | 2019-2024 | Verzenio, Jaypirca, Cyramza |
| Pfizer INC. | $126.76 | 2019-2024 | |
| Astellas Pharma US INC | $101.52 | 2019-2024 | Xtandi |
| Eisai INC. | $91.10 | 2019-2024 | |
| Tela Bio, INC. | $89.66 | 2021-2024 | Ovitex 2s, Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Daiichi Sankyo INC. | $85.67 | 2020-2023 | Injectafer |
| Allergan, INC. | $77.98 | 2019-2022 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mentor Worldwide LLC | $72.92 | 2021-2025 | Mentor Memorygel Resterilizable Gel Sizer |
| Davol INC. | $48.80 | 2025 | Phasix Mesh |
| Bayer Healthcare Pharmaceuticals INC. | $45.93 | 2019 | |
| Taiho Oncology, INC. | $44.96 | 2019 | |
| Cumberland Pharmaceuticals, INC. | $43.36 | 2019 | |
| Musculoskeletal Transplant Foundation INC. | $36.67 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $35.14 | 2019 | |
| Springworks Therapeutics, INC. | $33.92 | 2024 | Ogsiveo |
| Emd Serono, INC. | $27.83 | 2024 | |
| Seagen INC. | $25.34 | 2023 | Padcev |
| Array Biopharma INC | $23.21 | 2024 | Xalkori, Lorbrena, Braftovi |
| Janssen Biotech, INC. | $21.38 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $18.79 | 2025 | |
| Genentech USA, INC. | $17.12 | 2024 | Phesgo |
| Acacia Pharma INC | $15.58 | 2021 | |
| Puma Biotechnology, INC. | $12.21 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Liu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.